Laboratorio Reig Jofre, S.A.
RJF
Rank in Stocks
#15753
Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the... Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of a diverse range of medicines and nutritional supplements. Its extensive portfolio encompasses prescription drugs, over-the-counter (OTC) products, medical devices, and cosmetics. The company's offerings are categorized into several key areas: advanced pharmaceutical technologies, which include antibiotics and injectable formulations; specialized healthcare solutions targeting dermatological, musculoskeletal (joint health and pain), women's health, respiratory/ENT, and pediatric needs; and consumer health items marketed under its Forté Pharma brand. Furthermore, Laboratorio Reig Jofre provides contract development and manufacturing (CDMO) as well as contract manufacturing organization (CMO) services. Founded in 1929 and headquartered in Sant Joan Despí, Spain, the company sells its products directly in seven countries and collaborates with business partners to reach approximately 70 other nations. It operates as a subsidiary of Reig Jofre Investments SL.
Share Price
$2.87
Last synced: 2026-11-13
Market Cap
$235.77M
Change (1 day)
-1.90%
Change (1 year)
-8.62%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Laboratorio Reig Jofre, S.A. (RJF)
Category
Healthcare
Operating Margin for Laboratorio Reig Jofre, S.A. (RJF)
Operating Margin as of November 2026 TTM: 2.48%
According to Laboratorio Reig Jofre, S.A.'s latest financial reports, its current operating margin (TTM) is 2.48%. At the end of 2025 the company had an operating margin of 1.72%.
Operating Margin history for Laboratorio Reig Jofre, S.A. from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 2.48% | 44.19% |
| 2025 | 1.72% | -53.76% |
| 2024 | 3.72% | 11.71% |
| 2023 | 3.33% | 5.71% |
| 2022 | 3.15% | -16.00% |
| 2021 | 3.75% | -6.48% |
| 2020 | 4.01% | 26.90% |
| 2019 | 3.16% | -35.38% |
| 2018 | 4.89% | -8.94% |
| 2017 | 5.37% | -26.34% |
| 2016 | 7.29% | -2.67% |
| 2015 | 7.49% | -10.83% |
| 2014 | 8.40% | 30.84% |
| 2013 | 6.42% | 1,393.02% |
| 2012 | 0.43% | -100.76% |
| 2011 | -56.56% | 14.63% |
| 2010 | -49.34% | 350.59% |
| 2009 | -10.95% | -231.77% |
| 2008 | 8.31% | -196.40% |
| 2007 | -8.62% | -263.57% |
| 2006 | 5.27% | 37.96% |
| 2005 | 3.82% | -71.93% |
| 2004 | 13.61% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.69% | -92.06% |
DE
|
|
| 19.68% | -92.06% |
DE
|
|
| 13.26% | -94.65% |
JP
|
|
| 17.08% | -93.11% |
CH
|
|
| 10.53% | -95.75% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Laboratorio Reig Jofre, S.A.'s operating margin
What is Laboratorio Reig Jofre, S.A.'s operating margin?
Laboratorio Reig Jofre, S.A.'s operating margin is 2.48%, as of Nov 2026.
What was Laboratorio Reig Jofre, S.A.'s operating margin in 2025?
In 2025, Laboratorio Reig Jofre, S.A.'s operating margin was 1.72%, compared with 3.72% in 2024.
How has Laboratorio Reig Jofre, S.A.'s operating margin changed since 2020?
From 2020 to 2025, Laboratorio Reig Jofre, S.A.'s operating margin was highest in 2020 (4.01%) and lowest in 2025 (1.72%).
How does Laboratorio Reig Jofre, S.A.'s operating margin compare with similar companies?
Laboratorio Reig Jofre, S.A.'s operating margin (2.48%) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.